Gujarat Kidney Super Speciality Ltd vs Rainbow Childrens Medicare Ltd Stock Comparison
Gujarat Kidney Super Speciality Ltd vs Rainbow Childrens Medicare Ltd Stock Comparison
Last Updated on: Oct 25, 2026
Key Highlights
The Latest Trading Price of Gujarat Kidney & Super Speciality Ltd is ₹ 176.95 as of 23 Oct 15:30
. The P/E Ratio of Gujarat Kidney & Super Speciality Ltd changed from 51.4 on March 2026 to 51.4 on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Rainbow Childrens Medicare Ltd changed from 35.2 on March 2023 to 42.4 on March 2026 . This represents a CAGR of 4.76% over 4 years The Market Cap of Gujarat Kidney & Super Speciality Ltd changed from ₹ 798.29 crore on March 2026 to ₹ 798.29 crore on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Rainbow Childrens Medicare Ltd changed from ₹ 7412 crore on March 2023 to ₹ 11814 crore on March 2026 . This represents a CAGR of 12.36% over 4 years The revenue of Gujarat Kidney & Super Speciality Ltd for the Jun '26 is ₹ 34.98 crore as compare to the Mar '26 revenue of ₹ 31.29 crore. This represent the growth of 11.79% The revenue of Rainbow Childrens Medicare Ltd for the Jun '26 is ₹ 482.7 crore as compare to the Mar '26 revenue of ₹ 464.97 crore. This represent the growth of 3.81% The ebitda of Gujarat Kidney & Super Speciality Ltd for the Jun '26 is ₹ 9.07 crore as compare to the Mar '26 ebitda of ₹ 7.01 crore. This represent the growth of 29.39% The ebitda of Rainbow Childrens Medicare Ltd for the Jun '26 is ₹ 147.36 crore as compare to the Mar '26 ebitda of ₹ 148.23 crore. This represent the decline of -0.59% The net profit of Gujarat Kidney & Super Speciality Ltd changed from ₹ 2.96 crore to ₹ 5.32 crore over 9 quarters. This represents a CAGR of 29.77%
The net profit of Rainbow Childrens Medicare Ltd changed from ₹ 39.73 crore to ₹ 62.54 crore over 9 quarters. This represents a CAGR of 22.34%
The Dividend Payout of Gujarat Kidney & Super Speciality Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Rainbow Childrens Medicare Ltd changed from 13.22 % on March 2022 to 14.22 % on March 2026 . This represents a CAGR of 1.47% over 5 years .
About Gujarat Kidney & Super Speciality Ltd
Gujarat Kidney And Super Speciality Limited was incorporated under the name and style of Vihaan Medicare Private Limited', a private limited company, dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre.
Subsequently, the Company name was changed to Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad.
Further, Company' status was changed to a public limited company and the name of Company was changed to Gujarat Kidney and Super Speciality Limited' dated November 24, 2023 by the ROCs, Ahmedabad.
The Company operate a chain of mid-sized multispecialty healthcare institution and is engaged in providing comprehensive medical services, including inpatient and outpatient care, surgical procedures, diagnostic services, and emergency care.
About Rainbow Childrens Medicare Ltd
Rainbow Childrens Medicare Limited was originally incorporated as Rainbow Children's Medicare Private Limited' as Private Company dated August 7, 1998, issued by the Registrar of Companies, Hyderabad at Telangana.
Subsequently, the Company converted into a Public Limited, and name of the Company was changed to Rainbow Children's Medicare Limited' via fresh Certificate Incorporated issued by the RoC on November 20, 2021.
The Company is a leading chain of multi-specialty pediatric, and obstetrics & gynecology hospitals in India, operating 19 hospitals and 5 outpatient clinic centers across 6 cities, with a total bed capacity of 1,935 beds, five of which are NABH-accredited and three of which have 183 received EDGE certification.
The core specialties are Pediatrics and Obstetrics & Gynecology and emergency services.
FAQs for the comparison of Gujarat Kidney & Super Speciality Ltd and Rainbow Childrens Medicare Ltd
Which company has a larger market capitalization, Gujarat Kidney & Super Speciality Ltd or Rainbow Childrens Medicare Ltd?
Market cap of Gujarat Kidney & Super Speciality Ltd is 1,395 Cr while Market cap of Rainbow Childrens Medicare Ltd is 11,876 Cr
What are the key factors driving the stock performance of Gujarat Kidney & Super Speciality Ltd and Rainbow Childrens Medicare Ltd?
The stock performance of Gujarat Kidney & Super Speciality Ltd and Rainbow Childrens Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Gujarat Kidney & Super Speciality Ltd and Rainbow Childrens Medicare Ltd?
As of October 25, 2026, the Gujarat Kidney & Super Speciality Ltd stock price is INR ₹176.95. On the other hand, Rainbow Childrens Medicare Ltd stock price is INR ₹1169.3.
How do dividend payouts of Gujarat Kidney & Super Speciality Ltd and Rainbow Childrens Medicare Ltd compare?
To compare the dividend payouts of Gujarat Kidney & Super Speciality Ltd and Rainbow Childrens Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.